---
title: "Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296396513.md"
description: "On August 19, 2026, in Woburn, Massachusetts, Replimune Group, Inc. revealed that the Company's Chief Commercial Officer, Michelle DiNapoli, was granted inducement equity awards. Replimune Group, Inc., listed on NASDAQ as REPL, is a biotechnology company in the commercial stage focusing on innovative oncolytic immunotherapies."
datetime: "2026-08-19T20:02:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296396513.md)
  - [en](https://longbridge.com/en/news/296396513.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296396513.md)
generator: "portal-rs"
---

# Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

On August 19, 2026, in Woburn, Massachusetts, Replimune Group, Inc. revealed that the Company's Chief Commercial Officer, Michelle DiNapoli, was granted inducement equity awards. Replimune Group, Inc., listed on NASDAQ as REPL, is a biotechnology company in the commercial stage focusing on innovative oncolytic immunotherapies.

### Related Stocks

- [REPL.US](https://longbridge.com/en/quote/REPL.US.md)

## Related News & Research

- [Replimune grants CCO Michelle DiNapoli options for 150,000 shares at $15.58, plus 100,000 RSUs](https://longbridge.com/en/news/296394220.md)
- [Replimune FY27 Q1 net loss narrows to $69.8 million; R&D expenses fall to $49.3 million](https://longbridge.com/en/news/295931365.md)
- [Quantinno Capital Management LP Increases Stock Position in Replimune Group, Inc. $REPL](https://longbridge.com/en/news/296198190.md)
- [16:20 ETRobbins LLP Urges REPL Investors Who Lost Money Investing in Replimune to Contact the Firm for Information About Leading the Class Action](https://longbridge.com/en/news/296649920.md)
- [Vivmark Residential Required to Sell Two Boston Properties to Resolve Merger Concerns](https://longbridge.com/en/news/296261466.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**